This episode is part of ACC's ongoing effort to advance understanding of inflammation and its role in cardiovascular risk assessment. Drs. Antonio Abbate and Brittany Weber discuss the clinical relevance of high-sensitivity C-reactive protein (hs-CRP), including what it measures, which patients should be considered…
This episode is part of ACC's ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines. Join Drs. Pam Morris and Roger Blumenthal as they explore updates to the Dyslipidemia Guidelines, the patient populations who benefit most, and how to make sense of all of this new information. They provide a practical…
This episode is part of ACC's ongoing initiative to review aortic stenosis care and its approach to screening and diagnosis. Drs. Wayne Batchelor and Sammy Elmariah review the barriers to aortic stenosis diagnosis. The conversation highlights symptom variability, sex-based and demographic differences, and screening…
This episode is part of ACC's ongoing initiative on implementing the 2026 Dyslipidemia guidelines. Join Drs. Samuel Kim and Romit Bhattacharya as they review new therapeutic developments from the guidelines during this discussion on the intersections of dyslipidemia and cardiometabolic syndrome management. This…
This episode is part of ACC's ongoing initiative to recognize the risks and tackle management of hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG). Drs. Michael Miller and Archna Bajaj discuss the importance of correctly diagnosing sHTG, recognizing familial chylomicronemia syndrome (FCS), and…
In this CardiaCast episode, Kevin M. Alexander, MD is joined by Sarah Cuddy, MBBCh, to discuss the latest clinical data for investigational therapies and available treatments for transthyretin amyloid cardiomyopathy (ATTR-CM), as well as the potential implications of these findings on clinical practice and future…
This episode of CardiaCast will feature a discussion on risk assessment and genetics in the prevention of cardiovascular disease. This podcast is supported by Esperion, Merck, and Novartis.
This episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia. This podcast is supported by Esperion, Merck, and Novartis.
In this final episode of the Increasing Role of UACR in Cardiovascular Care series, Drs. Ankeet Bhatt and Brendan Neuen will break down why UACR screening is one of the most powerful yet underused tools for identifying early cardiovascular risk. Together, they examine the latest evidence on therapies and lifestyle…
The second episode of the Increasing Role of UACR in Cardiovascular Care series focuses on the most recent evidence-based guidelines for elevated UACR and related cardiovascular (CV) conditions. Dr. Ankeet Bhatt interviews Dr. Nihar Desai on key terminology for albuminuria and discuss CV conditions associated with…
This episode of CardiaCast will feature a discussion on the treatment of atherosclerotic cardiovascular disease (ASCVD) risk – from lifestyle to advanced therapies, led by Dr. Maya Safarova. The conversation covers lifestyle "therapy", the treatment algorithm for primary and secondary prevention, and what's on the…
In this first episode of The Increasing Role of Urine Albumin-Creatinine Ratio (UACR) in Cardiovascular Care series, Dr. Ankeet Bhatt interviews Dr. Katherine Tuttle on UACR, its role in kidney disease, and the importance of screening. Listen to Dr. Tuttle provide an overview of the most recent evidence-based…
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies
Apple Podcasts
Spotify
Website